Guillain-Barré syndrome related to SARS-CoV-2 infection.

The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) responsible for coronavirus disease 2019 (COVID-19) led to the death of thousands of people around the world.1 Neurologic manifestations are not much specific apart from acute anosmia, and postinfectious manifestation data are missing.2 We described the cases of 2 patients exhibiting demyelinating form of Guillain-Barre syndrome (GBS) and summarized neurologic manifestations and investigations results in table 1.